Manuela Doroana

878 total citations
24 papers, 357 citations indexed

About

Manuela Doroana is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Manuela Doroana has authored 24 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 15 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Manuela Doroana's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Manuela Doroana is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Manuela Doroana collaborates with scholars based in Portugal, United States and United Kingdom. Manuela Doroana's co-authors include Francisco Antunes, Ana E. Sousa, Rui M. M. Victorino, Fernando Maltêz, Helena Barroso, Nuno Taveira, Pedro Borrego, Perpétua Gómes, Cheila Rocha and Emília Valadas and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and AIDS.

In The Last Decade

Manuela Doroana

24 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuela Doroana Portugal 13 236 152 119 95 69 24 357
Radjin Steingrover Netherlands 11 418 1.8× 381 2.5× 91 0.8× 89 0.9× 135 2.0× 15 530
Ravinder Kaur Sachdeva India 9 141 0.6× 142 0.9× 57 0.5× 98 1.0× 79 1.1× 26 320
David A. Cooper Australia 9 335 1.4× 320 2.1× 71 0.6× 152 1.6× 100 1.4× 11 491
A. Pozniak United Kingdom 8 340 1.4× 338 2.2× 154 1.3× 157 1.7× 108 1.6× 19 567
Piera Pierotti Italy 10 272 1.2× 226 1.5× 104 0.9× 74 0.8× 29 0.4× 21 402
Katarina Gyllensten Sweden 9 159 0.7× 194 1.3× 43 0.4× 79 0.8× 42 0.6× 13 323
Jean‐Michel Livrozet France 9 120 0.5× 129 0.8× 42 0.4× 77 0.8× 30 0.4× 20 235
S Sabally Gambia 10 252 1.1× 211 1.4× 120 1.0× 153 1.6× 26 0.4× 10 442
Giuliana Cologni Italy 11 168 0.7× 215 1.4× 27 0.2× 141 1.5× 98 1.4× 20 358
Richard Loftus United States 6 460 1.9× 434 2.9× 124 1.0× 93 1.0× 76 1.1× 12 600

Countries citing papers authored by Manuela Doroana

Since Specialization
Citations

This map shows the geographic impact of Manuela Doroana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Doroana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Doroana more than expected).

Fields of papers citing papers by Manuela Doroana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Doroana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Doroana. The network helps show where Manuela Doroana may publish in the future.

Co-authorship network of co-authors of Manuela Doroana

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Doroana. A scholar is included among the top collaborators of Manuela Doroana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Doroana. Manuela Doroana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gori, Andrea, Manuela Doroana, Jürgen K. Rockstroh, et al.. (2015). Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programme. Journal of Infection. 71(6). 675–682. 1 indexed citations
2.
Matthews, Gail, Jacqueline Neuhaus, Sanjay Bhagani, et al.. (2015). Baseline prevalence and predictors of liver fibrosis amongHIV‐positive individuals: a substudy of theINSIGHTStrategic Timing of AntiRetroviral Treatment (START) trial. HIV Medicine. 16(S1). 129–136. 18 indexed citations
3.
Borges, Álvaro H., Jens Lundgren, Annalisa Ridolfo, et al.. (2014). Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease. AIDS. 28(17). 2565–2571. 5 indexed citations
4.
Carvalho, Armando, Manuela Doroana, José Carlos Soares de Fraga, et al.. (2014). O impacto da hepatite C em Portugal. 21(2). 44–54. 14 indexed citations
5.
6.
Perelman, Julian, Joana Alves, Céu Mateus, et al.. (2013). Direct treatment costs of HIV/AIDS in Portugal. Revista de Saúde Pública. 47(5). 865–872. 8 indexed citations
7.
Arribas, José Ramón, et al.. (2013). Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting. AIDS Research and Therapy. 10(1). 3–3. 20 indexed citations
8.
Borrego, Pedro, Charlotta Nilsson, Carlos Família, et al.. (2012). Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism. AIDS. 26(18). 2275–2284. 13 indexed citations
9.
Doroana, Manuela, et al.. (2012). Insights on treatment of a Portuguese cohort of HCV/HIV coinfected patients. Journal of the International AIDS Society. 15(S4). 1–1. 1 indexed citations
10.
Maltêz, Fernando, Manuela Doroana, Teresa Branco, & Cristina Valente. (2011). Recent advances in antiretroviral treatment and prevention in HIV-infected patients. Current Opinion in HIV and AIDS. 6. S21–S30. 14 indexed citations
11.
Valadas, Emília, Célia Carvalho, António Sarmento, et al.. (2011). Population mobility and the changing epidemics of HIV‐2 in Portugal. HIV Medicine. 13(4). 219–225. 11 indexed citations
12.
Borrego, Pedro, Inês Bártolo, Cheila Rocha, et al.. (2011). Baseline Susceptibility of Primary HIV-2 to Entry Inhibitors. Antiviral Therapy. 17(3). 565–570. 39 indexed citations
13.
Doroana, Manuela, et al.. (2010). Portuguese cohort: raltegravir with optimized background therapy (OBT) in multiple‐experienced HIV1‐ and HIV2‐infected patients. Journal of the International AIDS Society. 13(S4). 1 indexed citations
14.
Borrego, Pedro, Cheila Rocha, Manuela Doroana, et al.. (2008). The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients. Retrovirology. 5(1). 78–78. 19 indexed citations
15.
Nilsson, Charlotta, Helena Barroso, Perpétua Gómes, et al.. (2008). Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression. AIDS. 22(17). 2257–2265. 12 indexed citations
16.
17.
Martins‐Silva, J., Nuno C. Santos, Manuela Doroana, et al.. (2006). Changes in Blood Cell Membrane Properties in HIV Type-1-Infected Patients. AIDS Research and Human Retroviruses. 22(9). 849–853. 2 indexed citations
18.
Sousa, Ana E., et al.. (2000). Bulk Cytokine Production versus Frequency of Cytokine-Producing Cells in HIV1 Infection before and during HAART. Clinical Immunology. 97(2). 162–170. 8 indexed citations
19.
20.
Gatell, José M., Juan González‐Lahoz, Bonaventura Clotet, et al.. (1996). Switching from Zidovudine to Didanosine in Patients with Symptomatic HIV Infection and Disease Progression. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(3). 249–258. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Radjin Steingrover Breakdown of academic impact, for papers by Ravinder Kaur Sachdeva Breakdown of academic impact, for papers by David A. Cooper Breakdown of academic impact, for papers by A. Pozniak Breakdown of academic impact, for papers by Piera Pierotti Breakdown of academic impact, for papers by Katarina Gyllensten Breakdown of academic impact, for papers by Jean‐Michel Livrozet Breakdown of academic impact, for papers by S Sabally Breakdown of academic impact, for papers by Giuliana Cologni Breakdown of academic impact, for papers by Richard Loftus
Rankless by CCL
2026